Daily non-political popular news in brief.
Radiation after surgery keeps high-risk prostate cancer at bay
10-30-2007 · EurekAlert!An analysis of data involving more than 2,000 patients from 17 US institutions demonstrates that men with high-risk prostate cancer who receive radiation therapy after a prostatectomy were less likely to have a recurrence of disease. What's more, men whose cancer persists after surgery were less likely to see the cancer spread if they receive radiation.
Read more »
Keywords: radiation, surgery, keeps, high-risk, prostate, cancer, bay, keep, high, risk
« Previous | Next »
Similar news on "Radiation after surgery keeps high-risk prostate cancer at bay":
- Analysis: Older men treated for early prostate cancer
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- Analysis: Older men treated for early prostate cancer live longer than those not treated
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
01-02-2008 · EurekAlert!
Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years -- especially the development of bone metastases -- and increased survival in older men with potentially aggressive prostate cancer. This "neoadjuvant" hormonal therapy may allow men most at risk of developing bone metastases avoid long-term hormonal therapy later on.
Similar news · Read more »
- Tumors stopped from spreading to new sites
04-05-2007 · EurekAlert!
For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. Using a mouse model of breast cancer, researchers from Vanderbilt University have now generated evidence to suggest that treatment with TGF-beta inhibitors might help such patients.
Similar news · Read more »
- Veterans exposed to Agent Orange have higher rates of prostate cancer recurrence
05-20-2007 · EurekAlert!
Veterans exposed to Agent Orange have a 48 percent increased risk of prostate cancer recurrence following surgery than their unexposed peers, and when the disease comes back, it seems more aggressive, researchers say.
Similar news · Read more »
- Largest PSA bounce study eases worry of prostate cancer returning
11-08-2006 · EurekAlert!
Prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy -- called a PSA bounce -- are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise, according to the largest study of its kind presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Men, don't skip your prostate cancer treatment appointments!
10-30-2007 · EurekAlert!
Men with 'low risk' prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1,800 patients treated at Fox Chase Cancer Center in Philadelphia.
Similar news · Read more »
- Men with prostate cancer avoid radiation due to misconceptions
11-05-2006 · EurekAlert!
Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Adding radiation therapy for treatment of advanced prostate cancer may offer benefit
11-14-2006 · EurekAlert!
Treating advanced prostate cancer with radiation therapy after removal of the prostate gland reduces the risk of disease recurrence, but does not appear to significantly improve the length of survival, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
Similar news · Read more »
- Walking prevents bone loss caused from prostate cancer treatment
10-28-2007 · EurekAlert!
Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Similar news · Read more »
